Affiliation:
1. Department of Pathology and Laboratory Medicine, Albany Medical Center , Albany, NY , US
2. Dana Farber Cancer Institute , Boston, MA , US
3. Department of Pathology, Hacettepe University , Ankara, Turkiye
Abstract
Abstract
Objectives
Multinucleated tumor cells (MTCs) in clear cell renal cell carcinoma (ccRCC) are not well understood.
Methods
Our study included ccRCC cases in a single institution between 2010 and 2019. We classified MTC as MTC with degenerative atypia (MTCD), MTC with no anaplasia (MTCNA), and MTC with anaplasia (MTCA). Clinicopathologic characteristics and outcomes were compared between MTC groups.
Results
In all, 92 of 256 people (36%) with ccRCC had MTC. People with ccRCC with MTCD and those with ccRCC but no MTC had similar clinicopathologic characteristics and outcomes. Also, MTCNA and MTCA were associated with larger tumor size, advanced pathologic tumor stage, higher World Health Organization/International Society of Urologic Pathologists nuclear grade, and higher metastatic potential (P < .001 for each parameter). Overall, MTCA was associated with an increased rate of recurrence (P = .004), higher metastatic potential (P < .001), and shorter time to metastasis (P = .033), regardless of tumor stage. Univariate Cox regression revealed MTCNA as a significant predictor of metastasis at 5 years (hazard ratio [HR], 4.171; 95% CI, 1.934-8.998); moreover, MTCA was a significant predictor of recurrence (HR, 5.723; 95% CI, 2.495-13.124), metastasis (HR, 12.024; 5.966-24.232), and death (HR, 5.661; 95% CI, 2.688-11.924) at 5 years.
Conclusions
Although MTCD may not be relevant in tumor grading, MTCNA and MTCA are associated with adverse outcomes.
Publisher
Oxford University Press (OUP)
Reference16 articles.
1. The 2022 World Health Organization Classification of Tumours of the Urinary System and Male Genital Organs—Part A: Renal, Penile, and Testicular Tumours;Moch,2022
2. Clear cell renal cell carcinoma: validation of World Health Organization/International Society of Urological Pathology grading;Dagher,2017
3. The International Society of Urological Pathology (ISUP) grading system for renal cell carcinoma and other prognostic parameters;Delahunt,2013
4. Frequency, incidence and survival outcomes of clear cell renal cell carcinoma in the United States from 1973 to 2014: a SEER-based analysis;Feng,2019
5. Renal cell carcinoma with syncytial giant cell component;Lloreta,2002